L-Glutamic acid,N-[(2S)-1-oxo-2- (phosphonooxy)propyl]-L-ç-glutamyl-,1f5- ester with 1-deoxy-1-[8-(5'-guanylyloxy)-3,4- dihydro-2,4-dioxopyrimido[4,5-b]quinolin-10- (2H)-yl]-D-ribitol (95617-08-6)
Identification |
Properties |
Safety Data |
|
|
Other Product
- L-Glutamic acid,N-[(2S)-1-oxo-2-(phosphonooxy)propyl]-L-g-glutamyl-, 1®5-ester with1-[8-(5'-adenylyloxy)-3,4-dihydro-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl]-1-deoxy-D-ribitol
- L-Glutamic acid,N-[(2S)-1-oxo-2-(phosphonooxy)propyl]-L-g-glutamyl-, (1®5)-ester with1-deoxy-1-(3,4-dihydro-8-hydroxy-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol
- L-Glutamic acid,N-[N-[N-[1-oxo-2-(phosphonooxy)propyl]-L-g-glutamyl]-L-g-glutamyl]-, P®5-ester with 1-deoxy-1-(3,4-dihydro-8-hydroxy-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol,(S)- (9CI)
- Adenosine5'-(trihydrogen diphosphate), P'®5-ester with1-deoxy-1-(3,4-dihydro-8-hydroxy-7-methyl-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol(9CI)
- L-Aspartic acid,N-[4-carboxy-1-oxo-2-(phosphonooxy)butyl]-L-a-glutamyl-, 1®5'-ester with5-[4-[[1-(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-5-deoxy-1-O-a-D-ribofuranosyl-D-ribitol (9CI)
- D-Ribitol,1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-,5-(dihydrogen phosphate)
- D-Ribitol,1-deoxy-1-(3,4-dihydro-8-hydroxy-7-methyl-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-,5-(dihydrogen phosphate) (9CI)
- Adenosine5'-(trihydrogen diphosphate), P'®5-ester with1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-D-ribitol
- L-Glutamic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-(2-amino-1,4-dihydro-7-methyl-4-oxo-6-pteridinyl)ethyl]amino]phenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)
- D-Ribitol,1-deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxopyrimido[4,5-b]quinolin-10(2H)-yl)-
- L-Glutamic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-[(6S,7S)-2-amino-1,4,5,6,7,8-hexahydro-7-methyl-4-oxo-6-pteridinyl]ethyl]amino]phenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)
- 1-Deoxy-1-(2,3,4,10-tetrahydro-7,8-dimethyl-2,4-dioxopyrimido[5,4-b]quinolin-10-yl)-D-ribitol
- L-Aspartic acid,N-[(2S)-4-carboxy-1-oxo-2-(phosphonooxy)butyl]-, P®5'-ester with1-[4-[[(1R)-1-(2-amino-1,4-dihydro-4-oxo-6-pteridinyl)ethyl]amino]-2,5-dihydroxyphenyl]-1-deoxy-5-O-a-D-ribofuranosyl-D-ribitol (9CI)
- D-Ribitol,1-deoxy-1-(4-hydroxy-7,8-dimethyl-2-oxopyrido[2,3-b]quinoxalin-10(2H)-yl)-(9CI)
- 1-(4-Amino-2-imino-7,8-dimethylbenzo(g)pteridin-10(2H)-yl)-1-deoxy-D-ribitol
- Spiro[furan-3(2H),1'(2'H)-phenanthrene]-5(4H)-one,7'-[(O-6-deoxy-a-L-mannopyranosyl-(1®2)-O-[b-D-glucopyranosyl-(1®3)]-b-D-glucopyranosyl)oxy]dodecahydro-2'-[(2S,3S)-3-[(2R)-2-hydroxy-4-methyl-3-pentenyl]-3-methyloxiranyl]-4'b,8',8',10'a-tetramethyl-,(1'S,2'S,4'aR,4'bR,7'S,8'aR,10'aR)- (9CI)
- Spiro[furan-3(2H),1'(2'H)-phenanthren]-5(4H)-one,7'-[[6-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]dodecahydro-2'-(4-hydroxy-1,6-dimethyl-2-oxo-5-hepten-1-yl)-4'b,8',8',10'a-tetramethyl-,(1'S,2'R,4'aR,4'bR,7'S,8'aR,10'aR)-
- Spiro[furan-3(2H),1'(2'H)-phenanthrene]-5(4H)-one,7'-[[2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranosyl]oxy]-2'-[(2S,3S)-3-[(2R)-2-(b-D-glucopyranosyloxy)-4-methyl-3-pentenyl]-3-methyloxiranyl]dodecahydro-4'b,8',8',10'a-tetramethyl-,(1'S,2'S,4'aR,4'bR,7'S,8'aR,10'aR)- (9CI)
- L-Glutamic acid,N-[10-(2,6-diamino-1,4-dihydro-4-oxo-5-pyrimidinyl)-1-oxodecyl]-
- Benzoic acid,3-[1-(3-cyanopropyl)-1,4-dihydro-7-[[3-(4-morpholinyl)propyl]amino]-2,4-dioxopyrimido[4,5-d]pyrimidin-3(2H)-yl]-, ethyl ester